Abstract
Over the past decade, the treatment of ovarian cancer has been revolutionised by poly(ADP-ribose polymerase (PARP)) inhibitors. Based on the results f......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
